JP7031957B1 - 感染症検査方法 - Google Patents

感染症検査方法 Download PDF

Info

Publication number
JP7031957B1
JP7031957B1 JP2021568917A JP2021568917A JP7031957B1 JP 7031957 B1 JP7031957 B1 JP 7031957B1 JP 2021568917 A JP2021568917 A JP 2021568917A JP 2021568917 A JP2021568917 A JP 2021568917A JP 7031957 B1 JP7031957 B1 JP 7031957B1
Authority
JP
Japan
Prior art keywords
facility
sample
collection
information
sewage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021568917A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022201567A1 (enExample
Inventor
誠 八十島
公昭 嶽盛
ふみ 醍醐
卓哉 友野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Techno Research Inc
Original Assignee
Shimadzu Techno Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Techno Research Inc filed Critical Shimadzu Techno Research Inc
Priority to JP2022024052A priority Critical patent/JP7118370B1/ja
Application granted granted Critical
Publication of JP7031957B1 publication Critical patent/JP7031957B1/ja
Publication of JPWO2022201567A1 publication Critical patent/JPWO2022201567A1/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/10—Devices for withdrawing samples in the liquid or fluent state
    • G01N1/20—Devices for withdrawing samples in the liquid or fluent state for flowing or falling materials
    • G01N1/2035—Devices for withdrawing samples in the liquid or fluent state for flowing or falling materials by deviating part of a fluid stream, e.g. by drawing-off or tapping
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/26—Inoculator or sampler
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Sustainable Development (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hydrology & Water Resources (AREA)
  • Data Mining & Analysis (AREA)
  • Toxicology (AREA)
  • Databases & Information Systems (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
JP2021568917A 2021-03-25 2021-06-18 感染症検査方法 Active JP7031957B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022024052A JP7118370B1 (ja) 2021-03-25 2022-02-18 検査方法及び試料キット

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021052117 2021-03-25
JP2021052117 2021-03-25
PCT/JP2021/023270 WO2022201567A1 (ja) 2021-03-25 2021-06-18 感染症検査方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022024052A Division JP7118370B1 (ja) 2021-03-25 2022-02-18 検査方法及び試料キット

Publications (2)

Publication Number Publication Date
JP7031957B1 true JP7031957B1 (ja) 2022-03-08
JPWO2022201567A1 JPWO2022201567A1 (enExample) 2022-09-29

Family

ID=82849858

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2021568917A Active JP7031957B1 (ja) 2021-03-25 2021-06-18 感染症検査方法
JP2022024052A Active JP7118370B1 (ja) 2021-03-25 2022-02-18 検査方法及び試料キット
JP2022114813A Active JP7582272B2 (ja) 2021-03-25 2022-07-19 感染症検査システム
JP2024191592A Pending JP2025016645A (ja) 2021-03-25 2024-10-31 感染症検査方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022024052A Active JP7118370B1 (ja) 2021-03-25 2022-02-18 検査方法及び試料キット
JP2022114813A Active JP7582272B2 (ja) 2021-03-25 2022-07-19 感染症検査システム
JP2024191592A Pending JP2025016645A (ja) 2021-03-25 2024-10-31 感染症検査方法

Country Status (6)

Country Link
US (1) US20240142350A1 (enExample)
EP (1) EP4317395A4 (enExample)
JP (4) JP7031957B1 (enExample)
CN (1) CN116997662A (enExample)
AU (1) AU2021436402B2 (enExample)
WO (1) WO2022201567A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023210597A1 (ja) * 2022-04-25 2023-11-02 株式会社島津テクノリサーチ 試料採取装置

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024185253A1 (enExample) * 2023-03-08 2024-09-12

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011155919A (ja) * 2010-02-02 2011-08-18 Fisheries Research Agency ノロウイルス検出用材料および該材料を用いるノロウイルスの検出方法
US20200385296A1 (en) * 2019-06-04 2020-12-10 Biobot Analytics, Inc. Method for characterizing the prevalence of a biochemical condition within a population

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5319543A (en) * 1992-06-19 1994-06-07 First Data Health Services Corporation Workflow server for medical records imaging and tracking system
JPH11256543A (ja) * 1998-03-13 1999-09-21 Hitachi Ltd 感染症病原リスク管理マッピングシステム
US7399447B2 (en) 2004-04-01 2008-07-15 Enigma Science, Llc Active sampler for detecting contaminants in liquids
CN201395237Y (zh) 2009-03-27 2010-02-03 北京师范大学 应用于突发性污染河流应急处理的竹排式吸附筏
DE102009042056B4 (de) * 2009-09-15 2021-02-04 Mirion Technologies (Canberra CA) Ltd. Verfahren zur Erfassung einer Kontamination an einem bewegten Objekt
CN202297198U (zh) 2011-09-30 2012-07-04 北京师范大学 对溢油污染海水具有吸附功能的可生物降解浮床
JP2015143924A (ja) * 2014-01-31 2015-08-06 ケーディーアイコンズ株式会社 情報処理装置及びプログラム
EP3570315B1 (en) * 2015-03-06 2024-01-31 Micromass UK Limited Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of biopsy samples
CN111444279B (zh) * 2020-04-03 2023-04-21 长春市万易科技有限公司 一种基于区块链的人员流动记录系统及方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011155919A (ja) * 2010-02-02 2011-08-18 Fisheries Research Agency ノロウイルス検出用材料および該材料を用いるノロウイルスの検出方法
US20200385296A1 (en) * 2019-06-04 2020-12-10 Biobot Analytics, Inc. Method for characterizing the prevalence of a biochemical condition within a population

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Journal of Water Process Engineering, Available online 2021.01.29, Vol.40, 101947 (pp.1-10)
JOURNAL OF WATER PROCESS ENGINEERING, AVAILABLE ONLINE 2021.01.29, VOL.40, 101947 (PP.1-10), JPN6021051720, ISSN: 0004690632 *
Science of the Total Environment, Available online 2021.02.12, Vol.775, 145790 (pp.1-12)
SCIENCE OF THE TOTAL ENVIRONMENT, AVAILABLE ONLINE 2021.02.12, VOL.775, 145790 (PP.1-12), JPN6021051721, ISSN: 0004690633 *
京都市保健福祉局, 産学連携による新型コロナウイルスのモニタリング手法の開発について, [オンライン], 令, JPN6021033180, ISSN: 0004690631 *
京都市保健福祉局, 産学連携による新型コロナウイルスのモニタリング手法の開発について, [オンライン], 令和３年３月１８日（2021.03.18）, [検索日 2021.08.19], インターネット：<URL https://www.city.kyoto.lg.jp/gyozai/cmsfiles/contents/0000267/267621/0303180500sangakurenkei.pdf>

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023210597A1 (ja) * 2022-04-25 2023-11-02 株式会社島津テクノリサーチ 試料採取装置

Also Published As

Publication number Publication date
US20240142350A1 (en) 2024-05-02
JP7582272B2 (ja) 2024-11-13
JP2025016645A (ja) 2025-02-04
AU2021436402B2 (en) 2025-06-26
WO2022201567A1 (ja) 2022-09-29
JP2022151884A (ja) 2022-10-07
AU2021436402A1 (en) 2023-10-12
JP7118370B1 (ja) 2022-08-16
JP2022151641A (ja) 2022-10-07
JPWO2022201567A1 (enExample) 2022-09-29
EP4317395A1 (en) 2024-02-07
EP4317395A4 (en) 2024-09-11
CN116997662A (zh) 2023-11-03

Similar Documents

Publication Publication Date Title
Keshaviah et al. Developing a flexible national wastewater surveillance system for COVID-19 and beyond
JP2025016645A (ja) 感染症検査方法
Schmidt Watcher in the wastewater
Horman et al. Quantifying levels of wasted time in construction with meta-analysis
Boehm et al. Human norovirus (HuNoV) GII RNA in wastewater solids at 145 United States wastewater treatment plants: comparison to positivity rates of clinical specimens and modeled estimates of HuNoV GII shedders
World Health Organization Environmental surveillance for SARS-COV-2 to complement public health surveillance: interim guidance, 14 April 2022
Hrudey et al. The devil is in the details: emerging insights on the relevance of wastewater surveillance for SARS-CoV-2 to public health
Yoo et al. Economic evaluation of wastewater surveillance combined with clinical COVID-19 screening tests, Japan
Hrudey et al. Wastewater surveillance for SARS-CoV-2 RNA in Canada
Joung et al. Coupling wastewater-based epidemiological surveillance and modelling of SARS-COV-2/COVID-19: practical applications at the Public Health Agency of Canada
Scassa et al. The Datafication of Wastewater:: Legal, Ethical and Civic Considerations
Kirrage et al. Investigation of an outbreak of Legionnaires’ disease: Hereford, UK 2003
D’Aoust et al. SARS-CoV-2 viral titer measurements in Ontario, Canada wastewaters throughout the COVID-19 pandemic
Mastromonaco Hazardous waste hits Hollywood: Superfund and housing prices in Los Angeles
Cohen et al. Subsewershed SARS-CoV-2 wastewater surveillance and COVID-19 epidemiology using building-specific occupancy and case data
Neyra et al. Establishing a statewide wastewater surveillance system in response to the COVID-19 pandemic: a reliable model for continuous and emerging public health threats
Keck et al. Wastewater surveillance for SARS-CoV-2 at long-term care facilities: mixed methods evaluation
Maal-Bared et al. To sample or not to sample: A governance-focused decision tree for wastewater service providers considering participation in wastewater-based epidemiology (WBE) in support of public health programs
Tang et al. Exploration on wastewater-based epidemiology of SARS-CoV-2: Mimic relative quantification with endogenous biomarkers as internal reference
Rainey et al. Assessment of a mass balance equation for estimating community-level prevalence of COVID-19 using wastewater-based epidemiology in a mid-sized city
Matukas et al. Aggressively find, test, trace and isolate to beat COVID-19
Huang et al. Assessment of sanitation facilities in primary healthcare institutions across seven provinces in China: a cross-sectional study
Knutsson From end-use characterization to decentralized reuse design: closing the data-to-system gap
Murphree et al. La Crosse encephalitis surveillance using single versus paired serologic testing
Nikiforuk et al. Implementing wastewater surveillance for viral pathogens: lessons learned from SARS-CoV-2, monkeypox virus, norovirus and influenza A viruses

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211118

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20211118

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20211118

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20211203

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20211129

TRDD Decision of grant or rejection written
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211203

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220125

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220221

R150 Certificate of patent or registration of utility model

Ref document number: 7031957

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R157 Certificate of patent or utility model (correction)

Free format text: JAPANESE INTERMEDIATE CODE: R157